Skip to main content
. 2020 Dec;9(6):726–733. doi: 10.21037/tp-20-102

Figure 2.

Figure 2

Meta-analysis of the prognostic effects of KIT mutations in children with CBF-AML. (A) complete remission rate, (B) overall survival rate, (C) disease-free survival rate, (D) event-free survival rate, and (E) relapse rate.